Scott M Whitcup
CIK 1298941 · Executive VP, R&D, CSO · last filed 2025-12-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
6
Total Filings
71
Lifetime Open-Market Net
-$34.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | — | $4.36 | — | $0 | 8 | 2025-12-10 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | — | — | — | $0 | 3 | 2019-08-08 |
| NITE | Director | 0 | $37.45 | $0 | $0 | 2 | 2019-06-07 |
| ALLERGAN INC (AGN) Delisted | Executive VP, R&D, CSO | 18,964 | — | — | -$34.40M | 46 | 2015-02-24 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 4,183 | — | — | $0 | 3 | 2013-05-29 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 306,494 | — | — | $0 | 7 | 2013-02-19 |
Recent Filings · Page 7 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-02-20 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | +60,000 | $0 | EDGAR |
| 2009-02-04 | ALLERGAN INC (AGN) Delisted | Disp (D) | −584 | -$22.4K | EDGAR |
| 2008-02-25 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | +56,911 | $0 | EDGAR |
| 2008-02-19 | ALLERGAN INC (AGN) Delisted | Grant (A) | +5,997 | $0 | EDGAR |
| 2008-02-08 | ALLERGAN INC (AGN) Delisted | Tax (F) | −728 | -$48.5K | EDGAR |
| 2008-02-01 | ALLERGAN INC (AGN) Delisted | Tax (F) | −2,168 | -$138.8K | EDGAR |
| 2007-06-04 | ALLERGAN INC (AGN) Delisted | Mixed | — | -$124.4K | EDGAR |
| 2007-05-29 | ALLERGAN INC (AGN) Delisted | Mixed | — | -$1.9K | EDGAR |
| 2007-03-05 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | +44,248 | $0 | EDGAR |
| 2007-02-06 | ALLERGAN INC (AGN) Delisted | Grant (A) | +682 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.